3rd Annual GI Cancer Symposium: Focus on Pancreas and Hepatobiliary Cancers

This dynamic course is designed for physicians and healthcare professionals dedicated to the care of patients with hepatopancreaticobiliary and gastrointestinal cancers. Attendees will gain essential knowledge of the latest targeted and systemic therapies, with a particular emphasis on newly approved FDA agents for hepatopancreaticobiliary malignancies.

The curriculum also explores advancements in robotic surgery and new technology shaping pancreatic and liver procedures, highlighting best practices and technical innovations. Engaging sessions promote evidence-based approaches and foster collaboration among participants. Through expert-led discussions, attendees will discover practical strategies for integrating new treatments and surgical tools into clinical care.

The program encourages multidisciplinary learning, equipping participants with up-to-date insights and resources to enhance outcomes for patients with GI cancers. By the end of the course, healthcare providers will be empowered to deliver optimal care using the most current breakthroughs in their field.

1. Explore recent updates in robotic surgery and improved technology in pancreatic and liver surgery.
2. Identify new targeted and systemic therapies in the treatment of hepatopancreaticobiliary cancers with the focus on newly approved FDA agents.
3. Engage physicians and healthcare workers in best clinical practice in the treatment of GI cancers.

St. Elizabeth Healthcare is accredited by The Kentucky Medical Association to provide continuing medical education for physicians. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations received in writing no less than 7 days before the course will be refunded. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

St. Elizabeth Healthcare reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
St. Elizabeth Healthcare is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Welcome to the St. Elizabeth Healthcare Office of Continuing Education Faculty Portal.

Please complete the tasks assigned below. A Begin button indicates the task is incomplete, and an Update button indicates the task has been completed.

Mitigation of Relevant Financial Relationships

St. Elizabeth Healthcare is accredited by The Kentucky Medical Association to provide continuing medical education for physicians.

Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ashley Massman, BSHS
CME Program Coordinator
St. Elizabeth Healthcare
Edgewood , KY

Activity Administrator

Nothing to disclose

Minsig Choi, MD
Dr
St. Elizabeth
Cincinnati, OH

Co-Director

Speakers Bureau-Bristol-Myers Squibb Company|Speakers Bureau-Ipsen Biopharmaceuticals, Inc.|Consulting Fee-Natera

Brent T Xia, MD
St. Elizabeth Physicians / St. Elizabeth Healthcare
Cincinnati, OH

Co-Director, Faculty

Nothing to disclose

Ivan Bedoya Apraez, MD
Medial Oncologist Hematologist
St Elizabeth Physicians
EDGEWOOD, KY

Faculty

Nothing to disclose

Daniel Flora, MD
St Elizabeth Cancer Center
Cincinnati, OH

Faculty

Nothing to disclose

Olsi Gjyshi, MD

Faculty

Aditya Kalakonda, MD
St Elizabeth Physicians
Fort Thomas, KY

Faculty

Nothing to disclose

Philip Philip, MD
Wayne State University
Farmington Hills, MI

Faculty

Advisor-Bayer (Any division) (Relationship has ended)|Advisor-Jazz Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Novocure|Consulting Fee-Taiho Pharmaceutical (Relationship has ended)

Benjamin Tritle, MD
Radiology Associates of Northern Kentucky
Maineville, OH

Faculty

Nothing to disclose

Michele M Kenner, MHSA
AVP, Physician Services
St. Elizabeth Healthcare
Edgewood, KY

Other Planning Committee Member

Nothing to disclose

Thursday, October 16, 2025

Thank you to the following exhibitors:

• AstraZeneca 

• Bristol Meyers Squibb 

• Exelixis 

• Gilead 

• Incyte 

• Intera Oncology 

• Ipsen 

• Jazz Pharma

• Novartis 

• Salix